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Sir,
Treatment of orbital haemangiopericytoma with
surgery and preoperative embolization
We describe a case of extraconal orbital
haemangiopericytoma that was completely resected
following particle embolisation of the feeding artery.
Case report
A 22-year-old female patient presented with a 10-month
history of progressive ptosis, generalised
ophthalmoplegia, hypoglobus, and 6/6 visual acuity
(VA). MRI with contrast of the orbits revealed a well-
defined extraconal lesion above the superior rectus with
homogenous enhancement and multiple flow voids,
suggesting a vascular tumour. Cerebral angiography
demonstrated dense tumour staining, showing multiple
feeders to the tumour distal to origin of central retinal
artery (CRA). The ophthalmic artery was catheterised
using Marathon Flow Directed Micro Catheter (EV3;
Irvine, CA, USA) and a Mirage 0.008 Guidewire (EV3),
and safely placed distal to CRA (Figure 1a). Embosphere
particles measuring 150–300 mm were injected slowly
through distal ophthalmic artery into the tumour, under
constant blank roadmap, to prevent particles floating
retrogradely into the CRA. Approximately 95%
devascularisation of the tumour was achieved with a
small remnant feeder close to CRA (Figure 1b). Complete
excision via lid crease approach was performed
subsequently (Figures 2a and b).
Figure 1 (a, b) Pre- and post-embolisation of the lesion.
Figure 2 (a, b) Pre and post op picture of the patient.
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Histopathology revealed thin collagenous capsule
surrounding sheets of high density of oval cells with little
pleomorphism and moderate mitotic activity. Necrosis
was no seen. Tumour cells surrounded branching
capillaries, giving staghorn appearance.
Immunohistochemical stains of tumour cells were
positive for CD34, CD99, Bcl-2, and Vimentin and
negative for EMA, S-100, and SMA. The proliferative
index (Ki-67) was positive in 5% of the tumour cells.
These characteristic signs confirmed diagnosis of
haemangiopericytoma.
Patient maintained 6/5 VA 1-year following surgery.
Comment
Haemangiopericytoma of the orbit is a rare, slow
growing vascular tumour. Its incidence is 0.3–3% of all
orbital biopsies.1,2 Incomplete resection is associated with
a high rate of recurrence and malignant conversion.2
Complete removal of the lesion is considered the
mainstay treatment.3
Gear et al4 recommend radiotherapy for recurrent
superficial tumour, however, radiotherapy carries the
risk of ischaemic optic neuropathy, as does embolization.
Takahashi et al5 described excision of the lesion following
embolization by polyvinyl alcohol to reduce tumour size.
To the best of our knowledge, this is the first reported
case of haemangiopericytoma treated with particle
embolization followed by en bloc excision of the lesion.
Pre-excision embolization shrinks tumour, reducing the
risk of intraoperative haemorrhage. We recommend
preoperative embolization a useful technique for
haemangiopericytoma treatment.
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